Abiopharma

New Form 4 - INSMED Inc Filed: 2025-05-15 AccNo: 0001628280-25-025947 Size: 12 KB

New Form 10-Q - Cardio Diagnostics Holdings, Inc. Filed: 2025-05-15 AccNo: 0001553350-25-000044 Size: 5 MB

Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth

New Form 8-K - TuHURA Biosciences, Inc./NV Filed: 2025-05-15 AccNo: 0000950170-25-072685 Size: 269 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

SCYNEXIS Reports First Quarter 2025 FinancialResults and Provides Corporate Update

New Form SCHEDULE 13G/A - RHYTHM PHARMACEUTICALS, INC. Filed: 2025-05-15 AccNo: 0001104659-25-049479 Size: 15 KB

New Form SCHEDULE 13G - Neurogene Inc. Filed: 2025-05-15 AccNo: 0001104659-25-049481 Size: 21 KB

Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update

New Form 4 - Arcutis Biotherapeutics, Inc. Filed: 2025-05-15 AccNo: 0001415889-25-013137 Size: 11 KB

New Form 8-K - Rein Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001193125-25-120824 Size: 253 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G - CONDUIT PHARMACEUTICALS INC. Filed: 2025-05-15 AccNo: 0001641172-25-010946 Size: 13 KB

New Form 4 - Phathom Pharmaceuticals, Inc. Filed: 2025-05-15 AccNo: 0001415889-25-013134 Size: 11 KB

New Form 8-K - Fulgent Genetics, Inc. Filed: 2025-05-15 AccNo: 0000950170-25-072676 Size: 200 KB Item 5.07: Submission of Matters to a Vote of Security Holders

P3 Health Partners Announces First Quarter 2025 Results

New Form 4 - ELI LILLY & Co Filed: 2025-05-15 AccNo: 0000059478-25-000144 Size: 4 KB